Modafinil is a highly sought-after nootropic. Originally developed for sleep disorder conditions, its off-label use has ...

Neurocrine Biosciences exceeded earnings expectations for Q4 2024, driven by robust sales from key product Ingrezza, while revenue slightly missed estimates.

PHOENIX — Arizona is suing a major drug maker, accusing it of gaming the system by simply renaming an asthma drug to increase ...

State Budget 2025-26 lacks significant health sector improvements, with focus on senior citizen health and traditional medicine preservation.

Walgreens Boots Alliance, a leading pharmacy chain, announced that it was suspending its dividend program, which had been active for over 90 years. Walgreens isn't the only dividend-paying pharmacy ...

By: David McFaddin, President of Eastern Kentucky University For many Kentuckians including myself, the mission to improve ...